Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-02-25Clinical Trial Update: SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer
SWOG-9023 provides DNA analysis of tumor tissue from patients with metastatic kidney cancer; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery [Phase 1]
Phase 1 study evaluating AFP464 in patients with metastatic or unresectable solid tumors completed; the trial enrolled patients with various…
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Perifosine + Sunitinib Malate for Patients With Advanced Cancers [Phase 1]
Phase 1 study evaluating perifosine in combination with sunitinib malate for patients with advanced cancers has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: A Comparison of Nefopam-propacetamol Combination and Propacetamol for Postoperative Quality of Recovery After Laparoscopic Nephrectomy [NA]
A completed clinical trial comparing a nefopam-propacetamol combination with propacetamol for postoperative quality of recovery after laparo…
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers [Phase 1]
This document reports the completion of a Phase I study evaluating perifosine in combination with sorafenib in patients with advanced cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Effect of Ketorolac and Remote Ischemic Preconditioning on Renal Ischemia-reperfusion Injury in Patients Undergoing Partial Nephrectomy [NA]
This trial evaluated whether ketorolac and remote ischemic preconditioning can reduce renal ischemia-reperfusion injury during partial nephr…
-
CLINICAL_TRIALS trial_result · 2014-02-17Clinical Trial Update: Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of erlotinib and sirolimus for metastatic renal cell carcinoma has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial evaluating palliative radiofrequency ablation for metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment [Phase 4]
A Phase 4 trial evaluating everolimus in patients with metastatic renal cell carcinoma after progression on bevacizumab has completed, repor…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland
This completed clinical trial compared the cost and effectiveness of sunitinib versus interferon-alpha in treating renal cell carcinoma in F…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer [Phase 3]
Phase 3 trial update for axitinib in metastatic renal cell cancer has completed; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features [Phase 1]
Phase 1 clinical trial update for Seneca Valley Virus-001 with Cyclophosphamide in pediatric patients with relapsed/refractory neuroblastoma…
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma [Phase 1]
This is a Phase 1b study evaluating SGN-75 in combination with everolimus for renal cell carcinoma, which has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: Erlotinib in Treating Patients With Advanced Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating Erlotinib in advanced renal cell carcinoma has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma [Phase 2]
Phase 2 neoadjuvant trial evaluating bevacizumab for renal cell carcinoma has completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens
This completed clinical trial examined whether the clinical behavior of renal cell carcinoma after debulking nephrectomy correlates with tum…
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer [Phase 1, Phase 2]
This clinical trial update reports the termination of a Phase 1/2 study evaluating bevacizumab with or without MEDI-522 in patients with unr…
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial update evaluating bevacizumab plus interleukin-2 in metastatic renal cell carcinoma.
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer [Phase 2]
A Phase 2 clinical trial evaluating sunitinib given before and after surgery in patients with stage IV kidney cancer.
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: Interleukin-2 in Treating Patients With Metastatic Kidney Cancer [Phase 4]
This is a completed Phase 4 clinical trial update evaluating interleukin-2 in patients with metastatic renal cell carcinoma (kidney cancer).
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial update showing results for sunitinib in unresectable kidney cancer (renal cell carcinoma); results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer [Phase 2]
A Phase 2 clinical trial evaluating irradiated donor lymphocytes for metastatic renal cell carcinoma has terminated with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial update of UCN-01 in patients with advanced or metastatic renal cell carcinoma (kidney cancer) sponsored by UCSF.
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent
Pfizer sponsored a non-interventional study in Indian patients with advanced renal cell carcinoma treated with Sutent (sunitinib). The study…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer [Phase 3]
Phase 3 trial update evaluating interferon alfa with or without interleukin-2 and fluorouracil in advanced/metastatic kidney cancer. The stu…